{{Rsnum
|rsid=2946834
|Gene=IGF1
|Chromosome=12
|position=102394036
|Orientation=minus
|GMAF=0.3953
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 54.0 | 36.3 | 9.7
| HCB | 27.7 | 52.6 | 19.7
| JPT | 30.1 | 45.1 | 24.8
| YRI | 29.3 | 46.3 | 24.5
| ASW | 21.1 | 49.1 | 29.8
| CHB | 27.7 | 52.6 | 19.7
| CHD | 22.9 | 56.9 | 20.2
| GIH | 50.5 | 36.6 | 12.9
| LWK | 21.8 | 49.1 | 29.1
| MEX | 39.7 | 37.9 | 22.4
| MKK | 34.0 | 49.4 | 16.7
| TSI | 49.0 | 39.2 | 11.8
| HapMapRevision=28
}}{{PMID Auto
|PMID=21562710
|Title=Genotypes and phenotypes of IGF-I and IGFBP-3 in breast tumors among Chinese women
}}

{{PMID Auto
|PMID=21976954
|Title=IGF-1 gene polymorphisms in Polish families with high-grade myopia.
|OA=1
}}

{{PMID Auto
|PMID=17300730
|Title=Common genetic variation in IGF1, IGFBP-1, and IGFBP-3 in relation to mammographic density: a cross-sectional study.
|OA=1
}}

{{PMID Auto
|PMID=18199734
|Title=IGF-I and IGF-II genetic variation and breast cancer risk in Chinese women: results from the Shanghai Breast Cancer Study.
|OA=1
}}

{{PMID Auto
|PMID=18596909
|Title=IGF-1, IGFBP-1, and IGFBP-3 polymorphisms predict circulating IGF levels but not breast cancer risk: findings from the Breast and Prostate Cancer Cohort Consortium (BPC3).
|OA=1
}}

{{PMID Auto
|PMID=18772892
|Title=Can genes for mammographic density inform cancer aetiology?
|OA=1
}}

{{PMID Auto
|PMID=19240240
|Title=IGF-I and IGFBP-3 polymorphisms in relation to circulating levels among African American and Caucasian women.
|OA=1
}}

{{PMID Auto
|PMID=19551864
|Title=Genetic variation and circulating levels of IGF-I and IGFBP-3 in relation to risk of proliferative benign breast disease.
|OA=1
}}

{{PMID Auto
|PMID=20435602
|Title=Genetic association of insulin-like growth factor-1 polymorphisms with high-grade myopia in an international family cohort.
|OA=1
}}

{{PMID Auto
|PMID=20935157
|Title=Germline polymorphisms in genes involved in the IGF1 pathway predict efficacy of cetuximab in wild-type KRAS mCRC patients.
|OA=1
}}

{{PMID Auto
|PMID=23180020
|Title=Association of a common genetic variant of the IGF-1 gene with event-free survival in patients with HER2-positive breast cancer
}}

{{PMID Auto
|PMID=23397154
|Title=Common variants in IGF1 pathway genes and clinical outcomes after radical prostatectomy.
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}